---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-034786"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:53:53.198610+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Apimeds faces hostile takeover attempt by Inscobee; company says consent void, files emergency action

## Summary
- On March 20, 2026, Inscobee and Apimeds Korea claimed to remove all four directors and CEO/CFO via written consent.
- Company states the consent violates the irrevocable proxy granted under the Support Agreement from Dec 1, 2025.
- Inscobee used 6,416,365 shares subject to proxy; without those, consent lacks majority under Delaware law.
- Company will file emergency action in Delaware Court of Chancery under 8 Del. C. § 225 to void consent.
- Purported new board approved business expansions without authorization; company disputes them.

## SEC filing metadata
- accession: 0001213900-26-034786
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390026034786/0001213900-26-034786-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390026034786/ea0283550-8k_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-034786
- JSON: https://secwatch.observer/filing/0001213900-26-034786.json
- Plain text: https://secwatch.observer/filing/0001213900-26-034786.txt

## Key facts
- Governance Changes
  Apimeds Pharmaceuticals US, Inc.: Attempted amendment to the Amended and Restated Bylaws via stockholder written consent, which the company asserts is invalid.
  - Change: bylaw amendment
  source text: Because the Stockholder Consent is invalid, the amendment to the Amended and Restated Bylaws of the Company made in connection with the Stockholder Consent is invalid.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1894525/000121390026034786/0001213900-26-034786-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.